Ahmed Saad Elsaeidy, MD

USMLE Step1 | Clinical Researcher

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

Today, Dr Islam Mohammad Shehata told me that Dr Alan Kaye @alankaye01 mentioned my name in their call and said "He is brilliant", the feedback I am working hard to hear form scientists like Dr kaye.
I really thank them very much for their support.

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@MahmoudTablawy1 انا ممكن استوعب الزمكان بس صعب استوعب ال UW في شهرين

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@Ahmed_ElHadidy_ لوعندك تجنيد لازم تاخد نيابة جامعة ١٠٠% من خريجي طب دفعة اكتوبر ٢٥ حتى الان ضباط احتياط

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

📢 Join NeoEra – Research Opportunities! 🌍✨

I’ll share many research opportunities — open for international medical students, physicians, and researchers.

🔹 Stay tuned on new opportunities

👉 Join here: https://t.co/DLQNK5mChG
#research #opportunitiesinfo #USMLE #Medicine

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@MahM0ou الف مبروك يا غالي عقبال الماتش

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@MahM0ou الله يبارك فيك يا غالي عقبال step 2 و الماتش

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

﴿وَمَا بِكُم مِّن نِّعْمَةٍ فَمِنَ اللَّهِ﴾
فالحمد الكثير لله الذي وفقنا للسعى و تفضل علينا بالنجاح
"And whatever blessing you have – it is from Allah."
All praise and thanks be to Allah, Who enabled me to strive and graciously blessed me with success.
#USMLE #Step1 #Pass

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

⚠️Published during my dedicated period of USMLE Step 1 preparation:

7️⃣Immunosuppressant Use in Infective Endocarditis-Associated Glomerulonephritis: A Systematic Review

Clinical Drug Investigation

DOI: 10.1007/s40261-025-01461-8

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

⚠️ Published during my dedicated period of #USMLE Step 1 preparation:

6️⃣ Coinfections with monkeypox virus and varicella-zoster virus: a systematic review of case reports and case series
- Published in Archives of Virology (2025)
DOI: 10.1007/s00705-025-06359-6

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@Lucifer_M9 الله يبارك فيك يا حبيبي
ربنا يوفقنا جميعا باذن الله

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

Authors: Rahma Abdelaziz Ismail, Rahma Sameh Shaheen, Eslam Afifi, Reem Sayad, Leenah N. Sherif, Mohamed Ibrahim Aranda, Rawda A. Al Gohary, Ahmed Saad Elsaeidy

Key findings: Fezolinetant significantly reduced both frequency and severity of vasomotor symptoms

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

5️⃣ Efficacy and safety of fezolinetant and its different doses in the treatment of vasomotor symptoms in menopausal women: a systematic review and meta-analysis.
DOI: 10.1186/s43043-025-00231-y

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

Key findings: Fezolinetant significantly reduced both frequency and severity of vasomotor symptoms in postmenopausal women and improved quality of life scores, all while maintaining a favorable safety profile across various doses.

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@mofeeeeddd الله يبارك فيك .. اللهم امين

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@imadhak1m Thank you

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

- Key finding: New protective systems significantly reduce operator radiation exposure and fluoroscopy duration, though further research is needed to validate these benefits.

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

⚠️⚠️ New Publications to Announce – Completed during my dedicated period of #USMLE Step 1 preparation:

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

2️⃣ Efficacy of novel #radiation_protective systems during cardiac interventions: a systematic review and meta-analysis of RCTs
-Radiation and Environmental Biophysics (June 2025)

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@ibnYusufadewuyi Thank you

[Ahmed Saad Elsaeidy, MD @ElSaeidy_AS]

@zDrZee الله يبارك فيك يارب